BMA vs Cortisone for Glenohumeral Osteoarthritis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 8, 2015

Primary Completion Date

July 30, 2020

Study Completion Date

November 23, 2021

Conditions
Osteo Arthritis Shoulders
Interventions
DRUG

Cortisone

Patients randomized to receive this study intervention will undergo one ultrasound guided 80mg Depo Medrol GHJ injection

BIOLOGICAL

Bone Marrow Aspirate

Patients randomized to receive this study intervention will have, under sterile conditions and after injection of local anesthetic, 10 mls of bone marrow aspirate taken from the posterior superior iliac spine and injected under ultrasound guidance to the glenohumeral joint

Trial Locations (1)

M5S 1B2

Women's College Hospital, Toronto

All Listed Sponsors
collaborator

University of Toronto

OTHER

lead

Women's College Hospital

OTHER

NCT03580148 - BMA vs Cortisone for Glenohumeral Osteoarthritis | Biotech Hunter | Biotech Hunter